Christopher Ian Cookson

DxS Ltd. is a personalized medicine company which engages in the development and manufacture of companion diagnostic products. Its products make use of molecular diagnostics to aid doctors and drug companies in selecting therapies for patients. It offers its products, technology, and services to the healthcare industry to enable the delivery of safe and effective medicines. The company was founded by David Whitcombe in 2001 is headquartered in Manchester, the United Kingdom.

Part of Optibiotix Health Plc, Optibiotix Ltd. is a British company that develops biological products for digestive health. The company is based in Heslington, UK. The company was founded in 2012 by Stephen Patrick O'Hara, who has been the CEO since 2012. Optibiotix was acquired by Optibiotix Health Plc on August 05, 2014 for $122.72 million.

Bamburgh Capital Ltd. provides financial management services. Its services include strategic advisory, Initial Public Offering advisory, Equity Capital Markets advisory, mergers and acquisitions and disposal. The firm operates through its offices located in Manchester, Newcastle and Edinburgh. The company is headquartered in Manchester, the United Kingdom.

Horizon Discovery Ltd. develops and supplying patient-relevant drug discovery and diagnostic research tools. The frm also supplies genetically-defined cell lines, reporter gene assay kits, genomic reference standards and contract research services to organizations engaged in bio-pharmaceutical process optimization, drug discovery & development, and clinical diagnostic development. The company was founded by Christopher John Torrance and Alberto Bardelli on February 14, 2005 and is headquartered in Cambridge, the United Kingdom.

Collagen Solutions (UK) Ltd. manufactures medical grade biomedical collagen components for use in regenerative medicines, medical devices, and in-vitro diagnostics. It offers reagents and protocols; and specific collagen formulations for applications, such as sponges, films, and powders. The company is headquartered in London, the United Kingdom.

Cytox Ltd. develops products and services for neurodegenerative disorders. It develops cellular and genetic assays for Alzheimer’s disease diagnosis. The firm offers biomarker services to pharmaceutical companies conducting clinical trials with drugs for the treatment of AD and mild cognitive impairment; and drug-screening services. The company was founded by Zsuzsanna Nagy, Margaret Esiri, Roy Bicknell and James S. Chadwick in 2004 and is headquartered in Oxford, the United Kingdom.

The UK Innovation & Science Seed Fund LP, an evergreen fund, invests in seed-stage companies located in the United Kingdom. It targets companies operating in biotechnology, synthetic biology, engineering, agriculture, computer science, and environmental technology sectors. It provides equity financing for seed to early-stage transactions.

Sphere Medical Ltd. develops monitoring and diagnostic products to provide clinical and economic benefits in critical care environment. It offers microfabricated and transducers technologies. The company was founded in March 2002 by Gavin Troughton and is headquartered in Cambridge, the United Kingdom.

Source Bioscience Healthcare manufactures and supplies analytical testing laboratory products and provides laboratory services. The private company is based in Nottingham, UK.

Part of Ipca Laboratories Ltd., Onyx Research Chemicals Ltd. is a British company that operates as a parent company. The company is based in Sunderland, UK.

Jellagen Pty Ltd. produces research grade functional non-mammalian collagen products. The company was founded by Andrew Mearns Spragg and Alex Muhlholzl in May 2013 and is headquartered in Pembroke Dock, the United Kingdom.

Diagnostic Capital provides investment advice.

Momentum Bioscience Ltd. develops a technology for the detection of infection in blood and other normally sterile body fluids. Its solutions include EMA Sepsis, a detection method for organisms in blood; EMA Total, a detection method for organisms in NSF; EMA Bacteria for the detection of bacteria; and EMA Fungi for the detection of fungi. The company was founded by William Henry Mullen in 2008 and is headquartered in Cardiff, the United Kingdom.

Novel Technologies Holdings Ltd. operates as an investment holding company. The company was founded on May 24, 2017 and is headquartered in Manchester, the United Kingdom.

Onyx Scientific Ltd. provides pharmaceutical chemistry services. It offers lead optimization, chemical synthesis and process development, solid state chemistry, generic formulations, and pharmaceutical testing services. The company was founded by Denise Bowser and Anthony Flinn in 2000 and is headquartered in Sunderland, the United Kingdom.

SymCel AB develops and markets analytical instrumentations for cell biological research and development. Its products include calScreener, calPlate System, and calView date collection and analysis software. The company was founded by Dan Rolf Stefan Hallen and Bertil Ingemar Wadso in 2004 and is headquartered in Spanga, Sweden.

BBI Diagnostics Group Ltd. develops and manufactures raw materials and finished test platforms for the in-vitro diagnostics market. The firm’s products include cell culture reagents, conjugates, depleted serum, disease state plasma, enzymes, finished kits, gold nanoparticles, monoclonal antibodies, normal serums, patient samples, polyclonal antibodies, recombinant antibodies, silver nanoparticles, biothreat and explosives antibodies. It’s services include custom conjugation, lateral flow assay development, 3DNA pushing assay sensitivity to the limit, test optimisation, atomo rapid platform and the novarum reader. The company was founded by John Chandler in 1986 and is headquartered in Cardiff, the United Kingdom.

BgenuineTec Inc. engages in the development and sale of biometric technology products. The company provides biometric certification and authentication services, physical access systems, fingerprint image sensors, and related software. The company was founded in November 2005 and is headquartered in Tokyo, Japan.

Platform Diagnostics Ltd. develops vitro diagnostics products. It develops POC diagnostic devices based on capillary agglutination technology, a reagent that combines with an analyte in blood and urine samples, and forms an agglutinate of molecules. The company was founded by Damian Bond in 2002 and is headquartered in Ossett, the United Kingdom.

Quotient Diagnostics Ltd. develops diabetes testing technology. It offers pharmaceuticals, in vitro diagnostics and medical devices. The company was founded in December 2002 and is headquartered in Walton-on-Thames, the United Kingdom.

Part of Cardinal Health, Inc., Electro Medical Equipment Ltd manufactures medical devices and disposables for the non-invasive treatment of newborns with respiratory problems. The company is based in Brighton, UK. Electro Medical Equipment was acquired by VIASYS Healthcare, Inc. on October 17, 2002 for $22.33 million.